| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1147.143 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1147.143/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.143 |
| Version | 20210609 |
| Status | active |
| Date | 2021-06-09T01:00:50-04:00 |
| Name | BleedingAtCriticalSite |
| Title | Bleeding at Critical Site |
| Realm | us |
| Authority | hl7 |
| Description | The intent of the measure that this SNOMED CT value set was created for is focused on critical site bleeding that has an etiology of medication-related bleeding, specifically Venous Thromboembolism Pharmacoprophylaxis medications. |
| Purpose | (Clinical Focus: The purpose of this SNOMED CT value set is to identify critical site bleeding events during an encounter.),(Data Element Scope: This value set may use a model element related to Diagnosis.),(Inclusion Criteria: Includes concepts that represent SNOMED CT diagnoses that indicate a new onset of critical site bleeding of any kind.),(Exclusion Criteria: Excludes concepts that represent any diagnoses which may not always result in critical site bleeding Injury or traumatic causes of bleeding should be excluded. Nosebleeds and obstetric related bleeds are also excluded.) |
FHIR